D10Wsu102e Inhibitors
D10Wsu102e inhibitors are a specialized class of compounds designed to target the molecule or protein known as D10Wsu102e. Though specific information on D10Wsu102e may not be extensively documented, it likely represents a protein or enzyme involved in a distinct cellular or biochemical pathway. Inhibitors of D10Wsu102e function by binding to this target and interfering with its normal activity. This inhibition may prevent D10Wsu102e from performing its role in various molecular interactions, such as catalyzing a reaction, regulating other proteins, or participating in structural or signaling pathways. By disrupting these processes, D10Wsu102e inhibitors offer valuable insights into the biological significance of this molecule.
The mode of action for D10Wsu102e inhibitors likely involves interactions with key domains or structural elements of the target protein. These inhibitors may either mimic the natural substrates of D10Wsu102e or bind to specific active sites, thus blocking its ability to function properly. Alternatively, some inhibitors may act allosterically, altering the protein's conformation in a way that inhibits its activity. Inhibiting D10Wsu102e allows researchers to explore its role in cellular processes, including how it may influence cellular metabolism, signal transduction, or molecular assembly. The study of these inhibitors helps in understanding how D10Wsu102e operates within broader biochemical networks and can reveal the downstream effects of its inhibition on various biological systems. Through such inhibition, researchers can clarify the functional contributions of D10Wsu102e to cellular homeostasis and other critical functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMP-activated protein kinase (AMPK) activator, indirectly inhibits Gatd3a by promoting AMPK activation, leading to mitochondrial biogenesis and enhanced cellular energy status. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone, a mitochondrial complex I inhibitor, directly inhibits Gatd3a by disrupting electron transport chain function, leading to mitochondrial dysfunction and inhibition of Gatd3a activity. | ||||||
UK 5099 | 56396-35-1 | sc-361394 sc-361394A | 10 mg 50 mg | $236.00 $987.00 | 5 | |
UK5099, a mitochondrial pyruvate carrier (MPC) inhibitor, indirectly influences Gatd3a by disrupting mitochondrial pyruvate transport, leading to impaired tricarboxylic acid (TCA) cycle function and inhibition of Gatd3a. | ||||||
Lonidamine | 50264-69-2 | sc-203115 sc-203115A | 5 mg 25 mg | $105.00 $364.00 | 7 | |
Lonidamine, a mitochondrial hexokinase II inhibitor, indirectly inhibits Gatd3a by disrupting mitochondrial metabolism, leading to reduced ATP production and impairment of Gatd3a-dependent processes. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $77.00 $153.00 $240.00 | 8 | |
CCCP, a mitochondrial uncoupler, directly inhibits Gatd3a by disrupting the mitochondrial proton gradient, leading to decreased ATP synthesis and impairment of Gatd3a-dependent functions. | ||||||
(+)-Etomoxir sodium salt | 828934-41-4 | sc-215009 sc-215009A | 5 mg 25 mg | $151.00 $506.00 | 3 | |
Etomoxir, a carnitine palmitoyltransferase 1 (CPT-1) inhibitor, indirectly influences Gatd3a by disrupting fatty acid oxidation, leading to altered mitochondrial metabolism and inhibition of Gatd3a-dependent processes. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Antimycin A, a mitochondrial complex III inhibitor, directly inhibits Gatd3a by disrupting electron transport chain function, leading to mitochondrial dysfunction and inhibition of Gatd3a activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-DG, a glycolysis inhibitor, indirectly influences Gatd3a by disrupting glycolytic ATP production, leading to altered cellular energetics and impairment of Gatd3a-dependent mitochondrial processes. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
1,1-Dimethylbiguanide, Hydrochloride, an AMPK activator, indirectly inhibits Gatd3a by promoting AMPK activation, leading to enhanced mitochondrial biogenesis and improved cellular energy status, which inhibits Gatd3a-dependent processes. | ||||||